Fundraising Fox

EBR Systems

OTC: EBRCZ

Silicon Valley, AU · Founded 2003 · Delaware corporation · 157 employees on LinkedIn · 4 known investors

EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients. The company serves physicians and hospitals providing cardiac rhythm management and conduction system pacing solutions.

HealthtechMedical Devices

Founders & leadership

AW
Allan WillExecutive Chair
JM
John McCutcheonPresident, Chief Executive Officer
RR
Richard RileyNamed on SEC filing
LR
Leighton ReadNamed on SEC filing
AR
Allan R. WillNamed on SEC filing
PW
Parker WillisNamed on SEC filing
MC
Mark CowanNamed on SEC filing
JJ
Joshua J. BaltzellNamed on SEC filing
SO
Stephen O'ConnerNamed on SEC filing
SH
Stephen H. MahleNamed on SEC filing
WS
William StarlingNamed on SEC filing
DM
David MilneNamed on SEC filing

Investors · 4

Ascension VenturesSaint Louis · $10M – $20M
Emergent Medical Partners, LLPSan Jose
Runway Growth CapitalMenlo Park · $10M – $150M
Split Rock PartnersreportedEden Prairie · $2M – $40Mvia Dave Stassen · board

Reported raises · per SEC filings

Form D private placements

$84.6M disclosed across 4 rounds · 2014–2021

▶$8.7MraisedJul 2021 · 36 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • ALLAN WILLExecutive Officer, Director
  • JOHN MCCUTCHEONExecutive Officer, Director
  • DAVID STASSENDirector
  • LEIGHTON READDirector
  • TREVOR MOODYDirector
  • CHRIS NAVEDirector
Offering amount
$25M
Amount sold
$8.7M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$16.2MraisedOct 2019 · 35 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • ALLAN WILLExecutive Officer, Director
  • JOHN MCCUTCHEONExecutive Officer, Director
  • SUZANNE PILKINGTONExecutive Officer
  • LEIGHTON READDirector
  • TREVOR MOODYDirector
  • CHRIS NAVEDirector
  • DAVID STASSENDirector
Offering amount
$38.7M
Amount sold
$16.2M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$41MraisedNov 2017 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dave StassenDirector
  • Chris NaveDirector
  • Richard RileyExecutive Officer
  • Allan R. WillExecutive Officer, Director
  • Trevor MoodyDirector
  • Leighton ReadDirector
Offering amount
$56M
Amount sold
$41M
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.7MraisedJul 2014 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Allan R. WillExecutive Officer, Director
  • Parker WillisExecutive Officer
  • Mark CowanExecutive Officer
  • Joshua J. BaltzellDirector
  • Stephen O'ConnerExecutive Officer
  • Stephen H. MahleDirector
  • William StarlingDirector
  • David MilneDirector
  • Thomas FogartyDirector
  • John MaroneyDirector
  • Richard E. RileyExecutive Officer, Director
Offering amount
$35.6M
Amount sold
$18.7M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Rf Surgical23 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific22 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Oup13 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Topera12 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

Companies competing with EBR Systems for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does EBR Systems do?
EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients. The company serves physicians and hospitals providing cardiac rhythm management and conduction system pacing solutions.
Who are EBR Systems's investors?
EBR Systems's investors include Ascension Ventures, Emergent Medical Partners, LLP, Runway Growth Capital, Split Rock Partners.
How much funding has EBR Systems raised?
EBR Systems has disclosed $84.6M raised across 4 rounds.
Where is EBR Systems headquartered?
EBR Systems is headquartered in Silicon Valley, AU.